Get started
ORAGENICS INC COM USD0.001(POST REV SPLT)ORAGENICS INC COM USD0.001(POST REV SPLT)ORAGENICS INC COM USD0.001(POST REV SPLT)

ORAGENICS INC COM USD0.001(POST REV SPLT)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0A64 chart


Full chart

0A64 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.12 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.274 USD
Net income (FY)
‪−10.57 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪20.20 M‬
Beta (1Y)
2.25

Employees


Employees (FY)
3
Change (1Y)
−2 −40.00%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−3.52 M‬ USD

About Oragenics Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Janet Huffman
Website
oragenics.com
Headquarters
Sarasota
Founded
1996
FIGI
BBG00Z0Y4W66
Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Sarasota, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0A64 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 0A64.

Frequently Asked Questions


The current price of 0A64 is 0.202 USD — it has increased by 5.43% in the past 24 hours. Watch ORAGENICS INC COM USD0.001(POST REV SPLT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ORAGENICS INC COM USD0.001(POST REV SPLT) stocks are traded under the ticker 0A64.
0A64 stock has risen by 8.60% compared to the previous week, the month change is a 8.95% rise, over the last year ORAGENICS INC COM USD0.001(POST REV SPLT) has showed a −93.07% decrease.
We've gathered analysts' opinions on ORAGENICS INC COM USD0.001(POST REV SPLT) future price: according to them, 0A64 price has a max estimate of 1.00 USD and a min estimate of 1.00 USD. Watch 0A64 chart and read a more detailed ORAGENICS INC COM USD0.001(POST REV SPLT) stock forecast: see what analysts think of ORAGENICS INC COM USD0.001(POST REV SPLT) and suggest that you do with its stocks.
0A64 reached its all-time high on Feb 9, 2021 with the price of 111.600 USD, and its all-time low was 0.162 USD and was reached on Apr 9, 2025. View more price dynamics on 0A64 chart.
See other stocks reaching their highest and lowest prices.
0A64 stock is 5.15% volatile and has beta coefficient of 2.25. Track ORAGENICS INC COM USD0.001(POST REV SPLT) stock price on the chart and check out the list of the most volatile stocks — is ORAGENICS INC COM USD0.001(POST REV SPLT) there?
Today ORAGENICS INC COM USD0.001(POST REV SPLT) has the market capitalization of ‪4.17 M‬, it has increased by 15.29% over the last week.
Yes, you can track ORAGENICS INC COM USD0.001(POST REV SPLT) financials in yearly and quarterly reports right on TradingView.
ORAGENICS INC COM USD0.001(POST REV SPLT) is going to release the next earnings report on Aug 12, 2025. Keep track of upcoming events with our Earnings Calendar.
0A64 net income for the last quarter is ‪−2.22 M‬ USD, while the quarter before that showed ‪−3.35 M‬ USD of net income which accounts for 33.80% change. Track more ORAGENICS INC COM USD0.001(POST REV SPLT) financial stats to get the full picture.
No, 0A64 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 24, 2025, the company has 3 employees. See our rating of the largest employees — is ORAGENICS INC COM USD0.001(POST REV SPLT) on this list?
Like other stocks, 0A64 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORAGENICS INC COM USD0.001(POST REV SPLT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORAGENICS INC COM USD0.001(POST REV SPLT) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORAGENICS INC COM USD0.001(POST REV SPLT) stock shows the sell signal. See more of ORAGENICS INC COM USD0.001(POST REV SPLT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.